Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1703808rdf:typepubmed:Citationlld:pubmed
pubmed-article:1703808lifeskim:mentionsumls-concept:C0920434lld:lifeskim
pubmed-article:1703808pubmed:dateCreated1991-3-12lld:pubmed
pubmed-article:1703808pubmed:abstractTextSummarizing several studies, it can be shown that the new cell separator AS-104 (Fresenius), in comparison to the older systems, provides a real advantage concerning the separation efficiency, the purity of the platelet concentrates (PC), the platelet function and the donor safety. The results of 5 different separation protocols demonstrate the technical flexibility and developmental potential of this system. From the experience of 580 plateletapheresis runs the successful improvement of the cell separator, and the disposables can be documented as the frequency of disturbances and discontinuations are reduced considerably. The preliminary results of an uncontrolled, not randomized transfusion study of 244 transfusions in 49 patients show comparable posttransfusion increments as obtained with PC of the CS-3000 (Baxter).lld:pubmed
pubmed-article:1703808pubmed:languageenglld:pubmed
pubmed-article:1703808pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1703808pubmed:citationSubsetIMlld:pubmed
pubmed-article:1703808pubmed:statusMEDLINElld:pubmed
pubmed-article:1703808pubmed:issn1011-6974lld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:KretschmerVVlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:PrinzHHlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:GerlachAAlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:SöhngenDDlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:GöddeckeWWlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:MiddelbeckTTlld:pubmed
pubmed-article:1703808pubmed:authorpubmed-author:PflügerH HHHlld:pubmed
pubmed-article:1703808pubmed:issnTypePrintlld:pubmed
pubmed-article:1703808pubmed:volume26lld:pubmed
pubmed-article:1703808pubmed:ownerNLMlld:pubmed
pubmed-article:1703808pubmed:authorsCompleteYlld:pubmed
pubmed-article:1703808pubmed:pagination117-22lld:pubmed
pubmed-article:1703808pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:meshHeadingpubmed-meshheading:1703808-...lld:pubmed
pubmed-article:1703808pubmed:year1990lld:pubmed
pubmed-article:1703808pubmed:articleTitlePlateletapheresis with the new cell separator AS-104.lld:pubmed
pubmed-article:1703808pubmed:affiliationAbteilung für Transfusionsmedizin und Gerinnungsphysiologie, Universitätsklinikum, Marburg, FRG.lld:pubmed
pubmed-article:1703808pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1703808pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1703808pubmed:publicationTypeComparative Studylld:pubmed